ArticlePharmaceuticals (Basel, Switzerland)2022

Antibody-Based In Vivo Imaging of Central Nervous System Targets-Evaluation of a Pretargeting Approach Utilizing a TCO-Conjugated Brain Shuttle Antibody and Radiolabeled Tetrazines.

Christoph Bredack et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.